Home page2607 • HKG
add
Shanghai Pharmaceuticals Holding Co Ltd
Chiusura precedente
11,95Â $
Intervallo giornaliero
11,83Â $ - 12,07Â $
Intervallo annuale
10,06Â $ - 13,12Â $
Cap di mercato
64,25Â Mld HKD
Volume medio
2,38Â Mln
Rapporto P/E
6,98
Dividendo/Prezzo
3,77%
Notizie del mercato finanziario
Dati finanziari
Conto economico
Entrate
Utile netto
| (CNY) | set 2025info | Variazione Y/Y |
|---|---|---|
Entrate | 73,48Â Mld | 4,65% |
Spese di gestione | 5,58Â Mld | 14,38% |
Utile netto | 688,20Â Mln | -38,13% |
Margine di profitto netto | 0,94 | -40,51% |
Utili per azione | — | — |
EBITDA | 2,26Â Mld | -13,12% |
Aliquota fiscale effettiva | 32,89% | — |
Stato patrimoniale
Totale attivo
Totale passivo
| (CNY) | set 2025info | Variazione Y/Y |
|---|---|---|
Investimenti cash/breve termine | 44,55Â Mld | 5,10% |
Totale attivo | 236,75Â Mld | 5,81% |
Totale passivo | 147,12Â Mld | 4,65% |
Patrimonio netto totale | 89,62 Mld | — |
Azioni in circolazione | 3,71 Mld | — |
Prezzo/valore contabile | 0,58 | — |
Rendimento delle attività | 1,98% | — |
Rendimento sul capitale | 3,14% | — |
Flusso di cassa
Flusso di cassa netto
| (CNY) | set 2025info | Variazione Y/Y |
|---|---|---|
Utile netto | 688,20Â Mln | -38,13% |
Liquidità di esercizio | 1,36 Mld | -40,00% |
Liquidità da investimenti | 449,96 Mln | 126,86% |
Liquidità da finanziamenti | -4,31 Mld | -18,77% |
Flusso di cassa netto | -2,49Â Mld | 18,18% |
Flusso di cassa libero | -3,15Â Mld | -7,21% |
Informazioni
Shanghai Pharmaceuticals is a private-sector Chinese pharmaceutical company. The organization develops and distributes pharmaceutical products and operates in domestic and international markets.
Shanghai Pharma is the largest pharmaceutical and the first A+H listed company in China to be dual-listed by Shanghai and Hong Kong Stock Exchanges. As of 2020, the company made its presence to the Global Fortune 500 list with the ranking of 473, overall and 124 among 21 other Chinese companies on the list.
Shanghai Pharmaceuticals was founded in 1994 and is headquartered in Shanghai. As an investment holding company, it is actively engaged in research, manufacturing and distribution of pharmaceutical and healthcare products in China, that develops and distributes traditional Chinese and chemical drugs, chemical, biochemical and healthcare goods that are applied in various therapeutic fields, including immunoregulation and anti-cancer, immune system and digestion, cardiovascular and anti-infection, nervous system and mental disorder. Wikipedia
Fondazione
18 gen 1994
Sito web
Dipendenti
50.120
